![Investigator-initiated trials of targeted oncology agents: why independent research is at risk? | Semantic Scholar Investigator-initiated trials of targeted oncology agents: why independent research is at risk? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d41664533a3e1c07707bf920ad698a5a6ae7b1c3/3-Table1-1.png)
Investigator-initiated trials of targeted oncology agents: why independent research is at risk? | Semantic Scholar
PLOS ONE: Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries
![Investigator-initiated trials of targeted oncology agents: why independent research is at risk? - Annals of Oncology Investigator-initiated trials of targeted oncology agents: why independent research is at risk? - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/424ca98b-0673-4b87-bef8-067f7daf4b4d/gr1.jpg)
Investigator-initiated trials of targeted oncology agents: why independent research is at risk? - Annals of Oncology
![Improving and sustaining the site investigator community: Recommendations from the Clinical Trials Transformation Initiative - ScienceDirect Improving and sustaining the site investigator community: Recommendations from the Clinical Trials Transformation Initiative - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2451865419302248-gr2.jpg)
Improving and sustaining the site investigator community: Recommendations from the Clinical Trials Transformation Initiative - ScienceDirect
Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries | PLOS ONE
Investigator Initiated Trials (IIT) – Considerations and Guidance from the Perspective of Clinical Trial Supplies and GMP | ISPE | International Society for Pharmaceutical Engineering
![Navigating the differences between Investigator- Initiated v. Sponsor-Initiated Clinical Trials – What are the special contract and administration issues. - ppt download Navigating the differences between Investigator- Initiated v. Sponsor-Initiated Clinical Trials – What are the special contract and administration issues. - ppt download](https://images.slideplayer.com/13/3813471/slides/slide_4.jpg)
Navigating the differences between Investigator- Initiated v. Sponsor-Initiated Clinical Trials – What are the special contract and administration issues. - ppt download
![Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design | BMC Medical Research Methodology | Full Text Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-020-01125-5/MediaObjects/12874_2020_1125_Fig1_HTML.png)